Newron Pharmaceuticals
NWRN.SW
#8286
Rank
NZ$0.30 B
Marketcap
$15.97
Share price
-2.15%
Change (1 day)
98.36%
Change (1 year)

EPS for Newron Pharmaceuticals (NWRN.SW)

EPS in 2023: -$1.88

According to Newron Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.88. In 2023 the company made an earnings per share (EPS) of -$1.88 a decrease over its 2022 EPS that were of -$1.84.

EPS history for Newron Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023-$1.882.03%
2022-$1.8415.39%
2021-$1.60-31.32%
2020-$2.3314.74%
2019-$2.0336.6%
2018-$1.49159.87%
2017-$0.57-67.81%
2016-$1.78-39.24%
2015-$2.92107.61%
2014-$1.4115.8%
2013-$1.22119.91%
2012-$0.55-66.51%
2011-$1.65-71.49%
2010-$5.79-10.83%
2009-$6.4942.06%
2008-$4.5756.53%
2007-$2.92-52.84%
2006-$6.19-188.53%
2005$6.99